Strides Pharma Science Limited (star) Announces Strong FY26 Performance with 50% Yoy Growth

Strides Pharma Science Limited (STAR) reveals robust FY26 results with a 50% YoY growth in operational PAT and a 21% rise in Ex-US markets.